Sunday, August 31, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Oshkosh Receives Buy Rating Upgrade and Price Target Increase from DA Davidson Analyst

Elaine Mendonca by Elaine Mendonca
March 2, 2024
in Breaking News
0
Finance analyst
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On March 2, 2024, Oshkosh (NYSE: OSK) received a significant upgrade from neutral to buy by DA Davidson analyst Michael Shlisky. The price target was also raised from $122 to $130. This positive change in rating was influenced by the impressive guidance provided by Oshkosh’s CFO and VP, prompting a favorable reassessment by the analyst firm.

OSK Stock Shows Strong Performance Near 52-Week High: Positive Momentum Ahead

On March 2, 2024, OSK stock showed strong performance as it traded near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been on an upward trend in the long term, which may signal positive momentum for investors.

The price of OSK shares increased by $0.93 since the market last closed, representing a 0.84% rise. This increase brought the closing price of OSK stock to $111.79. Despite this rise, the stock remained unchanged in after-hours trading, suggesting that investors may be taking a cautious approach to the stock’s performance.

Overall, the performance of OSK stock on March 2, 2024, indicates that the stock is experiencing positive momentum and may continue to see growth in the future. Investors should keep an eye on any further developments in the stock’s performance to make informed decisions about their investments.

OSK Stock Performance Update: Revenue, Net Income, and EPS on the Rise

OSK stock has been performing strongly in the past year, with total revenue increasing by 16.5% to $9.65 billion. Net income also saw a significant increase, rising by 243.88% to $598.00 million. Earnings per share (EPS) also saw a substantial increase, rising by 245.29% to $9.08.

Overall, the performance of OSK stock on March 2, 2024, is quite positive, with strong growth in total revenue, net income, and EPS over the past year. While the fact that these metrics held flat since the last quarter may raise some concerns, the overall financial health of the company appears to be strong. Investors should continue to monitor OSK stock closely to see if this positive trend continues in the future.

Tags: OSK
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Capitalization

Analyst Reiterates Outperform Rating and Increases Price Target for Pennant Gr

Finance analyst

Analyst Upgrades Parker Hannifin to Market Perform

Fiances and technology

Analysts Upgrade Dell Technologies and Increase Price Targets

Recommended

Walgreens Stock

Walgreens Acquisition Clears Final Hurdle with Strong Bondholder Support

1 week ago
EEFT stock news

Anticipated Earnings Release and Stock Performance for Central Puerto NYSE CEPU

1 year ago
Mining Markets and money

Analyst Remains Positive on Sigma Lithiums Potential Despite Lowered Price Target

2 years ago
Healthcare Services Stock Exchange

Dexcom Inc Reports Impressive Financial Results and Promising Outlook for Continuous Glucose Monitoring

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe ADSK Alibaba AMD AMZN Apple AVGO BA Broadcom C Coinbase COST CRWD DIS DWAC Eli Lilly GM IBM INTC Intel Kraft Heinz LLY Lockheed META Micron MP Materials MSFT NFLX NIO Nvidia NVO Opendoor Oracle Palantir PLTR Red Cat Robinhood Rocket Lab USA SMCI Strategy Tesla TGT Tilray TSLA
No Result
View All Result

Highlights

Analysts Maintain Strong Buy Ratings for Curis Despite Stock’s Steep Decline

Jazz Pharmaceuticals Secures Dual Regulatory Wins for Oncology Drug

Leadership Transition at Simmons First National Amid Major Financial Restructuring

A Tale of Two Technologies: Cummins Navigates AI Boom and Green Transition

Construction Equity Defies Earnings Miss with Record Rally

American Rebel Holdings Faces Nasdaq Delisting Amid Financial Struggles

Trending

Paramount Stock
Market Commentary

Paramount’s Strategic Reboot: A New Era with Skydance and UFC Partnership

by Robert Sasse
August 31, 2025
0

Paramount Global has embarked on a comprehensive corporate transformation, culminating in a landmark merger and a groundbreaking...

Aldeyra Therapeutics Stock

Aldeyra Therapeutics Achieves Dual Regulatory Milestones for Key Drug Candidates

August 31, 2025
Semler Scientific Stock

Semler Scientific’s High-Stakes Bitcoin Bet Faces Mounting Pressure

August 31, 2025
Curis Stock

Analysts Maintain Strong Buy Ratings for Curis Despite Stock’s Steep Decline

August 31, 2025
Chimerix Stock

Jazz Pharmaceuticals Secures Dual Regulatory Wins for Oncology Drug

August 31, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Paramount’s Strategic Reboot: A New Era with Skydance and UFC Partnership August 31, 2025
  • Aldeyra Therapeutics Achieves Dual Regulatory Milestones for Key Drug Candidates August 31, 2025
  • Semler Scientific’s High-Stakes Bitcoin Bet Faces Mounting Pressure August 31, 2025

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com